A Support Vector Machine Based on Liquid Immune Profiling Predicts Major Pathological Response to Chemotherapy Plus Anti-PD-1/PD-L1 as a Neoadjuvant Treatment for Patients With Resectable Non-Small Cell Lung Cancer

The biomarkers for the pathological response of neoadjuvant chemotherapy plus anti-programmed cell death protein-1/programmed cell death-ligand 1 (PD-1/PD-L1) (CAPD) are unclear in non-small cell lung cancer (NSCLC). Two hundred and eleven patients with stage Ib-IIIa NSCLC undergoing CAPD prior to s...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jie, Zou, Dan, Han, Lijie, Yin, Zuomin, Hu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797141/
https://www.ncbi.nlm.nih.gov/pubmed/35095850
http://dx.doi.org/10.3389/fimmu.2021.778276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797141/
https://www.ncbi.nlm.nih.gov/pubmed/35095850
http://dx.doi.org/10.3389/fimmu.2021.778276

Ejemplares similares